We're thrilled to welcome Dermot Shortt as Chairman of Semeris – a transformative addition to our leadership team who brings the perfect blend of expertise in financial markets and technology innovation to accelerate our competitive advantage!
"To anyone, like me, who has seen structurers and lawyers agonise late into the night with multiple pdfs open while they edit a spreadsheet recording the data they need – Semeris kills that entire activity and brings document analytics into the AI world where it should be. I’m proud to be joining the team and look forward to the next growth stage."
Until April 2025, Dermot served as Chair of Finbourne Technology, which he co-founded in 2016. Today, his active portfolio spans MedTech SaaS (Full Health Medical) and board positions at cutting-edge companies like Zartis and Appital (observer), bringing fresh competitive intelligence from multiple high-growth sectors.
This fintech success builds on Dermot's 21-year career at UBS Investment Bank, where he co-founded UBS Delta, the bank's flagship risk management platform. After leading this business globally from 2008 to 2016, he knows exactly how to give institutional investors the technological edge they need to outperform.
With Semeris already serving 40+ distinguished clients across the entire CLO ecosystem – from leading managers and tranche investors to prestigious law firms and rating agencies – Dermot's dual expertise in risk management and technology scaling gives our community an unmatched advantage in the race for market leadership.
While competitors are still "Control-F-ing" through documents, we're building the future of legal document analysis with leadership that's already won in both Wall Street and Silicon Valley.
Welcome to the team, Dermot! Time to give capital markets the competitive edge they've been waiting for.